50 related articles for article (PubMed ID: 31488602)
21. Effects of compound-326, a selective delta-5 desaturase inhibitor, in ApoE knockout mice with two different protocols for atherosclerosis development.
Nagase H; Takagahara S; Satomi Y; Ando A; Kubo K; Ikeda S
J Pharm Pharm Sci; 2021; 24():71-83. PubMed ID: 33600308
[TBL] [Abstract][Full Text] [Related]
22. A Novel Selective Inhibitor of Delta-5 Desaturase Lowers Insulin Resistance and Reduces Body Weight in Diet-Induced Obese C57BL/6J Mice.
Yashiro H; Takagahara S; Tamura YO; Miyahisa I; Matsui J; Suzuki H; Ikeda S; Watanabe M
PLoS One; 2016; 11(11):e0166198. PubMed ID: 27832159
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-γ-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2.
Xu Y; Yang X; Zhao P; Yang Z; Yan C; Guo B; Qian SY
Free Radic Biol Med; 2016 Jul; 96():67-77. PubMed ID: 27101738
[TBL] [Abstract][Full Text] [Related]
24. Menhaden oil, but not safflower or soybean oil, aids in restoring the polyunsaturated fatty acid profile in the novel delta-6-desaturase null mouse.
Monteiro J; Li FJ; Maclennan M; Rabalski A; Moghadasian MH; Nakamura MT; Ma DW
Lipids Health Dis; 2012 May; 11():60. PubMed ID: 22642787
[TBL] [Abstract][Full Text] [Related]
25. Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque.
Powell DR; Gay JP; Smith M; Wilganowski N; Harris A; Holland A; Reyes M; Kirkham L; Kirkpatrick LL; Zambrowicz B; Hansen G; Platt KA; van Sligtenhorst I; Ding ZM; Desai U
Diabetes Metab Syndr Obes; 2016; 9():185-99. PubMed ID: 27382320
[TBL] [Abstract][Full Text] [Related]
26. A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in
Takagahara S; Shinohara H; Itokawa S; Satomi Y; Ando A; Yamamoto T; Suzuki H; Fujimoto T; Kubo K; Ikeda S
J Pharmacol Exp Ther; 2019 Nov; 371(2):290-298. PubMed ID: 31488602
[TBL] [Abstract][Full Text] [Related]
27. Delta-5-desaturase: A novel therapeutic target for cancer management.
Pang L; Shah H; Xu Y; Qian S
Transl Oncol; 2021 Nov; 14(11):101207. PubMed ID: 34438249
[TBL] [Abstract][Full Text] [Related]
28. A 'desaturase hypothesis' for atherosclerosis: Janus-faced enzymes in omega-6 and omega-3 polyunsaturated fatty acid metabolism.
Martinelli N; Consoli L; Olivieri O
J Nutrigenet Nutrigenomics; 2009; 2(3):129-39. PubMed ID: 19776640
[TBL] [Abstract][Full Text] [Related]
29. Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes.
Sergeant S; Rahbar E; Chilton FH
Eur J Pharmacol; 2016 Aug; 785():77-86. PubMed ID: 27083549
[TBL] [Abstract][Full Text] [Related]
30. [Biology of essential fatty acids (EFA)].
Dobryniewski J; Szajda SD; Waszkiewicz N; Zwierz K
Przegl Lek; 2007; 64(2):91-9. PubMed ID: 17892040
[TBL] [Abstract][Full Text] [Related]
31. Delta-5 and delta-6 desaturases: crucial enzymes in polyunsaturated fatty acid-related pathways with pleiotropic influences in health and disease.
Tosi F; Sartori F; Guarini P; Olivieri O; Martinelli N
Adv Exp Med Biol; 2014; 824():61-81. PubMed ID: 25038994
[TBL] [Abstract][Full Text] [Related]
32. A defect in the activity of Delta6 and Delta5 desaturases may be a factor in the initiation and progression of atherosclerosis.
Das UN
Prostaglandins Leukot Essent Fatty Acids; 2007 May; 76(5):251-68. PubMed ID: 17466497
[TBL] [Abstract][Full Text] [Related]
33. Recent insights into the relation of Δ5 desaturase and Δ6 desaturase activity to the development of type 2 diabetes.
Kröger J; Schulze MB
Curr Opin Lipidol; 2012 Feb; 23(1):4-10. PubMed ID: 22123669
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
